Evaluation of Disparities in Higher-Risk Myelodysplastic Syndromes (HR-MDS) Patient Treatment Patterns in a Large US Health System

被引：0
|
作者：
Moore, Kristin J. [1 ]
Engel-Nitz, Nicole M. [1 ]
McMahon, Peter [2 ]
Beal, Jason [2 ]
Jhaveri, Teraneh Z. [2 ]
Williamson, Mellissa [2 ]
Andrade, Katherine [1 ]
Landis, Christina [1 ]
Sadek, Islam [2 ]
Hogea, Cosmina [2 ]
机构：
[1] Optum, Eden Prairie, MN USA
[2] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182031
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Higher-Risk Myelodysplastic Neoplasms (HR-MDS) Patient Characteristics in a Large, Integrated United States (US) Healthcare System
    Moore, Kristin
    Engel-Nitz, Nicole
    McMahon, Peter
    Beal, Jason
    Jhaveri, Tizzy
    Williamson, Mellissa
    Andrade, Kate
    Landis, Christina
    Hogea, Cosmina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S365 - S365
  • [2] A Patient-Centered Programmatic Approach for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in the US Community Oncology Setting
    Rossetti, James M.
    Choksi, Rushir
    Vasudevan, Anupama
    Blanc, Simon
    Brenneman, Dawn
    Wang, Brandon
    McMahon, Peter
    Beal, Jason
    Jhaveri, Teraneh Z.
    Williamson, Mellissa
    Hogea, Cosmina
    BLOOD, 2023, 142
  • [3] TREATMENT PATTERNS IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS) IN ROUTINE CLINICAL CARE IN THE UNITED STATES (US) - A CLAIMS DATABASE STUDY
    Bell, J.
    Galaznik, A.
    Farrelly, E.
    Blazer, M.
    Shih, H-C.
    Raju, A.
    Ogbonnaya, A.
    Eaddy, M.
    Fram, R.
    Faller, D.
    HAEMATOLOGICA, 2017, 102 : 491 - 492
  • [4] EFFICACY OF CC-486 (ORAL AZACITIDINE) TREATMENT (TX) IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)
    Garcia-Manero, G.
    Savona, M. R.
    Gore, S. D.
    Conkling, P.
    Cogle, C. R.
    Hetzer, J.
    Dong, Q.
    Kumar, K.
    Ukrainskyj, S. M.
    Beach, C.
    Skikne, B. S.
    HAEMATOLOGICA, 2015, 100 : 239 - 239
  • [5] SURVIVAL OUTCOMES IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS) IN ROUTINE CLINICAL CARE IN THE UNITED STATES (US) - A CLAIMS DATABASE STUDY
    Bell, J.
    Galaznik, A.
    Farrelly, E.
    Blazer, M.
    Shih, H. -C.
    Raju, A.
    Ogbonnaya, A.
    Eaddy, M.
    Fram, R.
    Faller, D.
    HAEMATOLOGICA, 2017, 102 : 489 - 489
  • [6] Comparative Effectiveness of Azacitidine Versus Decitabine Among Older Adults Diagnosed with Higher-Risk Myelodysplastic Syndromes (HR-MDS)
    Zeidan, Amer M.
    Long, Jessica B.
    Hall, Jane
    Wang, Rong
    Huntington, Scott F.
    Abel, Gregory
    Prebet, Thomas
    Podoltsev, Nikolai A.
    Gross, Cary P.
    Gore, Steven D.
    Ma, Xiaomei
    Davidoff, Amy J.
    BLOOD, 2015, 126 (23)
  • [7] Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States
    Jill A. Bell
    Aaron Galaznik
    Marlo Blazer
    Huai-Che Shih
    Eileen Farrelly
    Augustina Ogbonnaya
    Michael Eaddy
    Robert J. Fram
    Douglas V. Faller
    PharmacoEconomics - Open, 2019, 3 : 237 - 245
  • [8] Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States
    Bell, Jill A.
    Galaznik, Aaron
    Blazer, Mario
    Shih, Huai-Che
    Farrelly, Eileen
    Ogbonnaya, Augustina
    Eaddy, Michael
    Fram, Robert J.
    Faller, Douglas, V
    PHARMACOECONOMICS-OPEN, 2019, 3 (02) : 237 - 245
  • [9] PATIENT-CENTRIC CARE (PCC) IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS): A GLOBAL SYSTEMATIC LITERATURE REVIEW (SLR) AND GAP ANALYSIS
    Armstrong, E. P.
    Franic, D.
    Malone, D. C.
    Pham, S., V
    Hogea, C.
    VALUE IN HEALTH, 2023, 26 (06) : S334 - S334
  • [10] Treatment Results of Intensive Chemotherapy for Higher-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia Related to MDS (MDS-AML)
    Kyo, Taiichi
    Yoshida, Noriaki
    Kyo, Kouhei
    Okatani, Takeshi
    Itagaki, Mitsuhiro
    Yuasa, Hiromi
    Iwato, Koji
    Asaoku, Hideki
    Katayama, Yuuta
    BLOOD, 2010, 116 (21) : 1209 - 1210
12345